A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis

NCT01927263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: NI-071
BIOLOGICAL: Infliximab

Sponsor

Nichi-Iko Pharmaceutical Co., Ltd.